← Back to all trials
Completed
NCT01679132
BAROSTIM NEO Hypertension Pivotal Trial
Conditions: Uncontrolled Hypertension
Sex: All
Ages: 21 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: CVRx, Inc.
Location: Arizona Heart Rhythm Research Center Phoenix Arizona
Summary
The purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the BAROSTIM Hypertension Pivotal Trial (G120137).
Eligibility Criteria
Inclusion Criteria:
* Actively participating in the Barostim Hypertension Pivotal Trial and currently implanted with the BAROSTIM NEO device with the device turned ON.
* Have signed a revised approved informed consent form for continued participation in this study.
Exclusion Criteria:
* Treating physician decision that the subject should not continue with therapy.
Source: ClinicalTrials.gov (NCT01679132). StuddyBuddy aggregates publicly available trial information.
